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Running Title: PLCηs in neuronal and neuroendocrine tissues 
Abstract 
Phosphoinositol-specific phospholipase C enzymes (PLCs) are central to inositol lipid 
signaling pathways, facilitating intracellular Ca2+ release and protein kinase C 
activation. A sixth class of Phosphoinositol-specific PLC with a novel domain 
structure, PLC-eta (PLCη) has recently been discovered in mammals. Recent 
research, reviewed here, shows that this class consists of two enzymes PLCη1 and 
PLCη2. Both enzymes hydrolyze phosphatidylinositol 4,5-bisphosphate and are more 
sensitive to Ca2+ than other PLC isozymes and are likely to mediate G-protein coupled 
receptor signaling pathways. Both enzymes are expressed in neuron-enriched regions, 
being abundant in the brain. We demonstrate that they are also expressed in 
neuroendocrine cell lines. PLCη enzymes therefore represent novel proteins 
influencing intracellular Ca2+ dynamics and protein kinase C activation in the brain 
and neuroendocrine systems.  
 
 
Keywords: Ca2+ signaling; protein kinase C; receptor-mediated signaling; 
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Introduction 
Phospholipase C enzymes (PLCs, EC 3.1.4.3) catalyze the cleavage of 
phosphatidylinositol 4,5-bisphosphate (PIP2) and result in the release of 1,2-
diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP3) from membranes in 
response to receptor activation. These products trigger the activation of protein kinase 
C and the release of Ca2+ from intracellular stores, respectively (1,2). They are crucial 
for initiation of cellular activation, proliferation, differentiation and apoptosis. Until 
recently, five distinct classes of PLCs that specifically react with 
phosphatidylinositols were known to exist in mammals, the β, γ, δ, ε and ζ-type 
enzymes (3,4). They have been classified on the basis of amino acid sequence, 
domain structure and amino acid similarity and by the mechanisms through which 
they are recruited in response to activated receptors. We, along with several other 
groups, identified a sixth class that was termed PLCη (5-8). Two putative PLCη 
enzymes were identified in humans and mice, PLCη1 and PLCη2 (5) and both were 
confirmed to catalyze hydrolysis of PIP2 (6-8) suggesting that PLCηs, like other 
PLCs, are involved in production of the secondary messengers DAG and IP3.  
 
Domain Structure of PLCη enzymes 
Like other mammalian PLCs, the domain structure of PLCηs consists of 
Pleckstrin homology (PH), EF-hand, catalytic X and Y domains and protein kinase C 
conserved region 2 (C2). Figure 1A shows the domain organization of all mammalian 
PLC-isozymes including all known forms of PLCη. Certain isoforms of PLCη1 and 
PLCη2 possess domain complements similar to PLCβ, which couple to G protein-
coupled receptors (GPCRs). The PH domain (absent in PLCζ; ~110 residues) binds 
polyphosphoinositides (9) and is present in many signaling proteins that associate 
with phospholipid membranes (10,11). This domain is not essential for membrane 
localization of PLCδ1 and PLCδ4 (6,12) but appears to be more important for 
membrane localization of PLCη2. Approximately 85% of native PLCη2 and 97% of a 
FLAG-tagged PLCη2 constructs were found to localize to plasma membrane, whereas 
only 6% of a PLCη2 construct with the PH domain removed was present at the cell 
surface (6). The role of the EF hand domain (~65 residues) in PLCs is unclear but the 
X-ray structure of PLCδ1 shows that it serves as a flexible “hinge-like” link between 
the PH and the catalytic domains (13). The X and Y domains (~150 and ~115 
residues, respectively) fold to form the catalytic site. The X domain is involved in 
both substrate and Ca2+ binding (which is essential for catalysis), while the Y domain 
primarily interacts with the substrate (13). These regions contain the highest degree of 
sequence identity (between 60-85%) among different mammalian PLCs (14). The C2 
domain is essential for catalytic activity (15) and is often associated with proteins that 
interact with phospholipids. In some PLCs the C2 domain binds Ca2+ and mediates 
Ca2+-dependent interactions with the lipid membrane. It has been speculated that the 
C2 domain of PLCδ1 may contain as many as four Ca2+-binding sites (15). PLCηs 
share a close evolutionary relationship with other PLC isozymes and are most closely 
related to the PLCδ class (5,6). However, unlike PLCδs, the PLCη enzymes contain 
an extended loop (~100 residues longer) between the X and Y domains and also 
include an additional C-terminal region that is rich in serine and proline residues. 
Serine- and proline-rich regions have proposed roles in protein-protein interactions 
(16,17). The C-terminal region of PLCηs are likely to be of functional yet undefined 
importance. 
PLCηs also contain a class II PDZ (post synaptic density protein, Drosophila 
disc large tumor suppressor, and zo-1 protein) conserved binding motif (PDZCBM; 
ΨXΨ-COOH, where Ψ represents a hydrophobic residue) at the C-terminus. PLCβs 
also contain a PDZCBM albeit a different motif (class I; (S/T)X(L/V)-COOH) and 
have been shown to be involved in the formation of multi-protein scaffolds including 
the InaD complex which mediates the assembly of photoreceptors via TRP channel 
activation (18,19) and the Na+/H+ exchanger regulatory factor 1-assembled complex 
in the kidney (20). It is therefore likely that in addition to classical PLC signaling 
PLCηs, like PLCβs, play role in the formation of PDZ multi-protein complexes. 
Three splice variants of PLCη1 and five splice variants of PLCη2 have been 
identified, all of which differ in length in the C-terminal region. The three variants of 
PLCη1, ‘a’, ‘b’ and ‘c’ encode human proteins of 1002, 1693 and 1035 amino acids, 
respectively (7). Interestingly, all three variants contain class II PDZCBM, although 
the actual sequence of the motif for PLCη1a (VQI-COOH) differs from that of PLCη1b 
and PLCη1c (LRL-COOH). This hints that variant ‘a’ may function as part of a 
different PDZ protein-scaffold than the other two variants. The five PLCη2 variants 
encode human proteins of 1416, 989, 1583, 1156 and 1211 amino acids and have been 
categorisd according to the exon structure of the spliced forms: ‘21a/23’, ‘21a/22/23’, 
‘21b/23’, ‘21b/22/23’ and ‘21c/22/23’, respectively (8). Of these five variants, only 
two (‘21a/23’ and ‘21b/23’) contain a class II PDZCBM (both LRL-COOH), whilst the 
other three variants do not contain a PDZCBM at all. This again suggests the potential 
for differing functions between spliced forms in vivo. 
 
Expression of PLCη enzymes 
 Murine PLCη1 expression has been investigated by RT-PCR using primer 
pairs targeting a common region of the three splice variants and also for the PLCη1a 
variant only (7). In the range of tissues examined the PCR products of the common 
region were most abundant in brain and kidney but were also observed in lung, 
spleen, intestine, thymus and pancreas. PLCη1a was detected in the brain and lung 
only. Immunoblotting confirmed expression of PLCη1a protein in neuronal tissues 
such as cerebrum, cerebellum and spinal cord. In situ hybridization revealed a high 
level of expression throughout the brain, especially in neuronal cell enriched regions 
such as the inner layer of the olfactory bulb, the hippocampus, Purkinje layer of 
cerebellum, cerebral cortex, zona incerta, habenular nuclei and hypothalamus (7). RT-
PCR and Northern blot analyses have shown that PLCη2 gene expression is 
detectable in both brain and intestine of mice (5,6). In addition, expressed sequence 
tags (ESTs) corresponding to human PLCη2 were identified in cDNAs isolated from a 
range of neuron-rich tissues including anaplastic oligodendroglioma, epithelioid 
carcinoma, leukopheresis, lymph, nerve tumor, optic nerve, pancreatic islet, pituitary 
and retinoblastoma cell populations (5). Immunoblot analysis detected PLCη2 
expression in the brain but not in a variety of other murine tissues including small 
intestine, heart, skeletal muscle, kidney, liver, lung, testis or spleen (6). Expression of 
PLCη2 protein in the brain was found to be developmentally dependent, being 
detectable 1-2 weeks after birth. It was also detected at high levels in neuron-
containing primary cultures but not in astrocyte cultures. In situ hybridization on 
murine tissue sections showed gene expression in pyramidal cells of the olfactory 
bulb, hippocampus and cerebral cortex, three regions where PLCη1 is also expressed.  
The hippocampus and cerebral cortex are involved in memory and learning 
(21,22). The olfactory bulb functions in odor and pheromone perception and is also 
involved in neuro-hormonal programming of the hypothalamo-pituitary axis (23,24). 
PLCη enzymes may therefore play a vital role in neural signaling pertaining to 
memory and learning or neuron-hormonal regulation. This hypothesis is consistent 
with the observation that PLCη2 increases with post natal age. In addition PLCη2 was 
found to have a very similar expression pattern to that of neuron marker protein, 
microtubule-associated protein 2 (MAP2) (6). This suggests that PLCη2 is 
particularly likely to be involved in some aspect of neural or neuroendocrine 
functioning. 
Further evidence that PLCη2 may play a role in the hypothalamo-pituitary axis 
has come from recent work in our laboratory where we have found this protein to be 
present in the GnRH neuronal cell line, GT1-7 and in the LβT2 and αT3 pituitary cell 
lines but not in HEK293 cells (Figure 1B). HEK293 cells were used as a negative 
control due to the absence of product when mRNA isolated from these cells was 
assayed by RT-PCR using primers able to detect human PLCη2 transcript. The GT1-7 
cell line is a well-characterized model of the hypothalamic neuron able to secrete 
gonadotropin-releasing hormone (GnRH) in culture (25). LβT2 and αT3 cells are 
pituitary gonadotrope-like cells, which express GnRH receptor and can be stimulated 
to release the pituitary hormones luteinizing hormone and follicle stimulating 
hormone (26,27). Given the presence of PLCη2 in these neuroendocrine cells as well 
as neurons, a possible role for PLCη2 may affect vesicle exocytosis. This process is 
not only Ca2+-driven but requires formation of pre-synaptic-like PDZ domain-protein 
complexes at the surface of the cell membrane (28,29).   
 
Regulation and Differential Ca2+ Sensitivity   
 In the recent study by Zhou et al. (8), co-expression of PLCη2 with the G 
proteins, Gβ1 and Gγ2 resulted in elevated PLC activity in COS-7 cells. This suggests 
that PLCη2 may be activated in response to G protein-coupled receptor activation. 
Gβγ dimers have also been shown to activate PLCβ1-3 and PLCε (30-32) through 
interaction with the PH domain (33). Whether the observed Gβγ-mediated stimulation 
of PLC activity in PLCη2 is a direct or indirect effect remains to be examined. 
However, sequence analysis reveals that several key residues in the PH domain of 
bovine GSK2 that are known to directly bind Gβγ are conserved. These include 
Arg587 (which corresponds to Arg78 in PLCη2) and is essential for Gβγ-induced 
activation of this enzyme (34). 
All PLC isozymes can be activated by Ca2+ in vitro, but PLCδ1 is more 
sensitive to Ca2+ compared with the other isozymes and it can be constitutively 
tethered to PIP2-containing membranes via its PH domain in the absence of other 
signals (35). It has therefore been speculated that an increase in the intracellular Ca2+ 
to a level sufficient to fix the C2 domain of PLCδ1 to the membrane, triggers its 
activation (35). Thus, it has been postulated that activation of PLCδ1 isozymes may 
occur following receptor-mediated activation of other PLC isozymes (36). 
Interestingly, PLCη1 and PLCη2 exhibit Ca2+-dependent (PIP2)-hydrolyzing activity 
in vitro but differ greatly, compared with other PLCs, in their sensitivity toward Ca2+. 
Both enymes display maximal activity at a Ca2+ concentration of ~1µM (6,7), which 
is at least 10-fold lower than that required by PLCδ1 (6). Increased sensitivity means 
that PLCηs may catalyse PIP2-hydrolysis at much lower Ca2+ concentrations than 
PLCδ1 in vivo and indicate that like the PLCδ class, PLCη2 may not necessarily be 
linked to receptor-mediated activation. Alternatively, this enzyme may amplify the 
signaling events of other PLCs or even Ca2+ channels. A speculative representation of 
PLCη signaling is shown in Figure 2. Kinetic analyses for either of the PLCη 
enzymes have yet to be performed but it would be interesting to determine whether 
PIP2-hydrolysis occurs at a comparable or faster rate than other PLC enzymes under 
physiological conditions. If so, PLCη2 may facilitate very rapid communication 
between cells due to its elevated Ca2+ sensitivity. 
Analysis of the Ca2+-mediated lipid-binding site in the C2 domain of 
synaptotagmin I (a Ca2+-activated vesicle protein) shows that it consists of four 
aspartate residues, Asp172, Asp178, Asp230 and Asp232 (37). All four of these 
residues are conserved in the C2 domain of the PLCη enzymes but not in PLCδ1, 
where Asp172 is equivalent to Asn645 (38). Ca2+ ions would therefore be expected to 
bind more tightly at this site in synaptotagmin I and the PLCηs than to PLCδ1. This 
may explain the greater Ca2+-sensitivity exhibited by PLCηs. Other PLCs such as the 
PLCβ and PLCγ enzymes also contain a C2 domain, yet here the key residues 
involved in Ca2+ binding are not conserved (39). 
In conclusion, PLCη enzymes represent an exciting new discovery in the field 
of neurophysiology and molecular data suggests the basis for their involvement in 
novel protein networks relaying Ca2+-signaling and protein kinase C activation. Such 
networks are likely to be of great importance in the brain and neuroendocrine tissues. 
Our recent data suggest that neuroendocrine cell lines may be appropriate tools to 
begin examining the cell biology of PLCηs. It is hoped that these findings stimulate 
further research towards elucidating their physiological function.  
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Figure legends 
FIG. 1. A. Domain organization in murine PLC-isozymes including all known forms 
of PLCηs (yellow box). PH, Pleckstrin homology domain; EF, EF-hand domain; X, 
catalytic X domain; Y, catalytic Y domain; C2, C2 domain; SH, Src homology 
domain; RasGEF, guanine nucleotide exchange factor domain for Ras-like small 
GTPases; RA, Ras association domain; PDZ, post synaptic density protein, 
Drosophila disc large tumor suppressor, and zo-1 protein C-terminal binding motif. B. 
Western blot showing presence of PLCη2 in mouse GT1-7 neuronal, and LβT2 and 
αT3 neuroendocrine cells. 
 
FIG. 2. Schematic representation of putative PLCη signaling. PLCη catalyzed 
cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2) results in the generation of 
1,2-diacylglycerol and inositol 1,4,5-triphosphate (IP3). These products stimulate Ca2+ 
release and protein kinase C (PKC) activation. In vivo PLCη2 may undergo receptor-
mediated activation via interaction with Gβγ or in response to a small elevation in 
levels of cytoplasmic Ca2+. PLCηs may also be involved in vesicle exocytosis through 
association with PDZ protein scaffolds.  
Figure 1. 
 
EF X Y C2PLCη1a PH
EF X Y C2PLCη1b PH
EF X Y C2PLCη1c PH
EF X Y C2PLCη2 PH
EF X Y C2PLCζ
PH EF X Y C2PLCβ
PH EF X Y C2PLCδ
PH EF X Y C2SH2SH2 SH3PLCγ P H
PHRasGEF EF X Y C2 RA1 RA2PLCε
EF X Y C2PLCη2 PH
EF X Y C2PLCη2 PH
EF X Y C2PLCη2 PH
EF X Y C2PLCη2 PH
1002 aa
1693 aa
1035 aa
PDZ
PDZ
PDZ
PDZ
PDZ
PDZ
21a/23
21a/22/23
21b/23
21b/22/23
21c/22/23
1416 aa
989 aa
1583 aa
1156 aa
1211 aa
HEK293
(-ve control) GT1-7 LβT2 αT3
A
B
Figure 2. 
 
 
PIP2 DAG
Ca2+
PKC
Cellular response 
Ras/Raf/MEK/ERK
pathway
Ca2+
IP3
Ca2+ channel
sensitive to IP3
Endoplasmic
reticulum
Receptor-mediated
activation
Cellular response
Gβ1 Gγ2
Gα
Gβ1γ2 activates 
PLC-η2
Vesicle exocytosis
YX
PH EF C2
neurotransmitter
or hormone
vesicle-membrane 
fusion scaffold?
PDZ
Membrane-docked 
vesicle
